2012/2232(DCE) | [ParlTrack]

download json

2012/2232(DCE) Declaration on tackling multiple sclerosis in Europe

Progress: Procedure completed

Legal Basis:

RoP 136_

Subjects

4.20.01 Medicine, diseases

Events

2012/09/13

EP - Decision by Parliament

Details

The European Parliament adopted a declaration signed by 408 Members on tackling multiple schlerosis in Europe.

It recalls that approximately 600 000 Europeans suffer from multiple schlerosis (MS) which is the most common neurodegenerative disorder and is a major cause of non-traumatic disability in young adults. Most people with MS are diagnosed in the prime of their working lives, and almost half leave the workforce within three years of diagnosis.

Given that in Europe tremendous discrepancies in access to disease-modifying treatments and quality of care exist, Parliament calls on the Commission and the Council to:

encourage, within the framework of Horizon 2020, closer scientific collaboration and comparative research on MS; promote, in their Reflection Process on Chronic Disease, equal access to treatment and flexible employment policies for people with chronic neurological disorders such as MS.

It also calls on the Member States to enhance equal access to quality care , for example, by using certified educational training tools (such as ‘MS Nurse Professional’) to develop, standardise and benchmark specialist nursing staff training, as well as to support the European Register for MS by encouraging patient data collection at national level.

Documents

T7-0357/2012

2012/09/13

EP - End of procedure in Parliament

History

(these mark the time of scraping, not the official date of the change)

2021-12-18Show (4) Changes | Timetravel

events/0	date 2012-09-13T00:00:00 type Decision by Parliament body EP docs url: https://www.europarl.europa.eu/doceo/document/TA-7-2012-0357_EN.html title: T7-0357/2012 summary The European Parliament adopted a declaration signed by 408 Members on tackling multiple schlerosis in Europe. It recalls that approximately 600 000 Europeans suffer from multiple schlerosis (MS) which is the most common neurodegenerative disorder and is a major cause of non-traumatic disability in young adults. Most people with MS are diagnosed in the prime of their working lives, and almost half leave the workforce within three years of diagnosis. Given that in Europe tremendous discrepancies in access to disease-modifying treatments and quality of care exist, Parliament calls on the Commission and the Council to: encourage, within the framework of Horizon 2020, closer scientific collaboration and comparative research on MS; promote, in their Reflection Process on Chronic Disease, equal access to treatment and flexible employment policies for people with chronic neurological disorders such as MS. It also calls on the Member States to enhance equal access to quality care , for example, by using certified educational training tools (such as ‘MS Nurse Professional’) to develop, standardise and benchmark specialist nursing staff training, as well as to support the European Register for MS by encouraging patient data collection at national level.
events/0	date 2012-09-13T00:00:00 type Decision by Parliament, 1st reading/single reading body EP docs url: http://www.europarl.europa.eu/doceo/document/TA-7-2012-0357_EN.html title: T7-0357/2012 summary The European Parliament adopted a declaration signed by 408 Members on tackling multiple schlerosis in Europe. It recalls that approximately 600 000 Europeans suffer from multiple schlerosis (MS) which is the most common neurodegenerative disorder and is a major cause of non-traumatic disability in young adults. Most people with MS are diagnosed in the prime of their working lives, and almost half leave the workforce within three years of diagnosis. Given that in Europe tremendous discrepancies in access to disease-modifying treatments and quality of care exist, Parliament calls on the Commission and the Council to: encourage, within the framework of Horizon 2020, closer scientific collaboration and comparative research on MS; promote, in their Reflection Process on Chronic Disease, equal access to treatment and flexible employment policies for people with chronic neurological disorders such as MS. It also calls on the Member States to enhance equal access to quality care , for example, by using certified educational training tools (such as ‘MS Nurse Professional’) to develop, standardise and benchmark specialist nursing staff training, as well as to support the European Register for MS by encouraging patient data collection at national level.
procedure/legal_basis/0	Rules of Procedure EP 136_
procedure/legal_basis/0	Rules of Procedure EP 136

2020-01-19Show (1) Changes | Timetravel

events/0/docs/0/url

Old

http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P7-TA-2012-357

New

http://www.europarl.europa.eu/doceo/document/TA-7-2012-0357_EN.html

2019-07-06Show (9) Changes | Timetravel

activities	date: 2012-09-13T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P7-TA-2012-357 type: Decision by Parliament, 1st reading/single reading title: T7-0357/2012 body: EP type: Decision by Parliament, 1st reading/single reading
committees
events	date: 2012-09-13T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P7-TA-2012-357 title: T7-0357/2012 summary: The European Parliament adopted a declaration signed by 408 Members on tackling multiple schlerosis in Europe. It recalls that approximately 600 000 Europeans suffer from multiple schlerosis (MS) which is the most common neurodegenerative disorder and is a major cause of non-traumatic disability in young adults. Most people with MS are diagnosed in the prime of their working lives, and almost half leave the workforce within three years of diagnosis. Given that in Europe tremendous discrepancies in access to disease-modifying treatments and quality of care exist, Parliament calls on the Commission and the Council to: encourage, within the framework of Horizon 2020, closer scientific collaboration and comparative research on MS; promote, in their Reflection Process on Chronic Disease, equal access to treatment and flexible employment policies for people with chronic neurological disorders such as MS. It also calls on the Member States to enhance equal access to quality care , for example, by using certified educational training tools (such as ‘MS Nurse Professional’) to develop, standardise and benchmark specialist nursing staff training, as well as to support the European Register for MS by encouraging patient data collection at national level. date: 2012-09-13T00:00:00 type: End of procedure in Parliament body: EP
links
other
procedure/legal_basis/0	Rules of Procedure EP 136
procedure/legal_basis/0	Rules of Procedure of the European Parliament EP 136
procedure/subject	Old 4.20.01 Medicine, diseases New 4.20.01 Medicine, diseases
procedure/type	Old DCE - Written declaration New DCE - Written declaration (historic)

2014-11-09Show (4) Changes | Timetravel

activities/0/docs/0/text/0	Old The European Parliament adopted a declaration signed by 408 Members on tackling multiple schlerosis in Europe. It recalls that approximately 600 000 Europeans suffer from multiple schlerosis (MS) which is the most common neurodegenerative disorder and is a major cause of non-traumatic disability in young adults. Most people with MS are diagnosed in the prime of their working lives, and almost half leave the workforce within three years of diagnosis. Given that in Europe tremendous discrepancies in access to disease-modifying treatments and quality of care exist, Parliament calls on the Commission and the Council to: encourage, within the framework of Horizon 2020, closer scientific collaboration and comparative research on MS; promote, in their Reflection Process on Chronic Disease, equal access to treatment and flexible employment policies for people with chronic neurological disorders such as MS. It also calls on the Member States to enhance equal access to quality care, for example, by using certified educational training tools (such as ‘MS Nurse Professional’) to develop, standardise and benchmark specialist nursing staff training, as well as to support the European Register for MS by encouraging patient data collection at national level. New The European Parliament adopted a declaration signed by 408 Members on tackling multiple schlerosis in Europe. It recalls that approximately 600 000 Europeans suffer from multiple schlerosis (MS) which is the most common neurodegenerative disorder and is a major cause of non-traumatic disability in young adults. Most people with MS are diagnosed in the prime of their working lives, and almost half leave the workforce within three years of diagnosis. Given that in Europe tremendous discrepancies in access to disease-modifying treatments and quality of care exist, Parliament calls on the Commission and the Council to: encourage, within the framework of Horizon 2020, closer scientific collaboration and comparative research on MS; promote, in their Reflection Process on Chronic Disease, equal access to treatment and flexible employment policies for people with chronic neurological disorders such as MS. It also calls on the Member States to enhance equal access to quality care, for example, by using certified educational training tools (such as ‘MS Nurse Professional’) to develop, standardise and benchmark specialist nursing staff training, as well as to support the European Register for MS by encouraging patient data collection at national level.
activities/0/type	Old Written declaration New Decision by Parliament, 1st reading/single reading
procedure/legal_basis/0	Old Rules of Procedure of the European Parliament EP 123 New Rules of Procedure of the European Parliament EP 136
procedure/subject/0	Old 4.20.01 Medicine, diseases, AIDS New 4.20.01 Medicine, diseases

2012-09-23Show (1) Changes | Timetravel

activities/0/docs/0/text

The European Parliament adopted a declaration signed by 408 Members on tackling multiple schlerosis in Europe.

It recalls that approximately 600 000 Europeans suffer from multiple schlerosis (MS) which is the most common neurodegenerative disorder and is a major cause of non-traumatic disability in young adults. Most people with MS are diagnosed in the prime of their working lives, and almost half leave the workforce within three years of diagnosis.

Given that in Europe tremendous discrepancies in access to disease-modifying treatments and quality of care exist, Parliament calls on the Commission and the Council to:
- encourage, within the framework of Horizon 2020, closer scientific collaboration and comparative research on MS;
- promote, in their Reflection Process on Chronic Disease, equal access to treatment and flexible employment policies for people with chronic neurological disorders such as MS.
It also calls on the Member States to enhance equal access to quality care, for example, by using certified educational training tools (such as ‘MS Nurse Professional’) to develop, standardise and benchmark specialist nursing staff training, as well as to support the European Register for MS by encouraging patient data collection at national level.

2012-09-17Show (5) Changes

activities	date: 2012-09-13T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P7-TA-2012-357 type: Decision by Parliament, 1st reading/single reading title: T7-0357/2012 body: EP type: Written declaration
committees
links
other
procedure	reference 2012/2232(DCE) title Declaration on tackling multiple sclerosis in Europe legal_basis Rules of Procedure of the European Parliament EP 123 stage_reached Procedure completed type DCE - Written declaration subject 4.20.01 Medicine, diseases, AIDS

Progress: Procedure completed

Legal Basis:

Subjects

Links

Events

History

ParlTrack - 2011-2024